Yellow fever vaccine

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 1972 English Publisher:Springer Science and Business Media LLCJournal:Archiv f�r die gesamte Virusforschung, volume 37, pages 211-217 (issn: 0304-8608, eissn: 1432-8798,

Copyright policy )

Authors: Nicola M. Tauraso; Sheldon L. Spector; Roy W. Trimmer;

doi: 10.1007/bf01268003

Yellow fever vaccine

- Summary
- Metrics

Abstract

Removal of avian leukosis viruses (ALV), which have contaminated the yellow fever (YF) 17 D vaccine since its development in the middle 1940's, had no effect upon the antigenicity of this vaccine in rhesus monkeys. From results of plaque neutralization tests, the high degree of antigenicity of the 17 D vaccine was confirmed.

Related Organizations

National Institutes of Health
United States
National Institute of Health
Pakistan

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average